Skip to main content

Humacyte, Inc.

HUMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001818382

In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Humacyte, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of HUMA: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6975+6
Shares12.1M14.7M+2.67M (+22.1%)
Value$37.4M$42.2M+$4.80M (+12.8%)

New holders (13)

Institutions that held Humacyte, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to HUMA in Q2 2023
InstitutionSharesValue% of portfolio
Davidson Kempner Capital Management LP450,000$1.28M0.03%
Luminus Management LLC400,000$1.14M0.34%
Norges Bank374,176$1.07M0.00%
Gsa Capital Partners LLP148,585$425.0K0.04%
Rokos Capital Management LLP89,903$264.8K0.01%
Citadel Advisors LLC39,089$111.8K0.00%
Josh Arnold Investment Consultant, LLC38,000$108.7K0.11%
Curi Capital35,440$101.4K0.01%
State Board of Administration of Florida Retirement System17,390$49.7K0.00%
Bayesian Capital Management, LP10,541$30.1K0.00%
Simplex Trading, LLC3,974$11.0K0.00%
Group One Trading, L.P.2,860$8.18K0.00%
O'Dell Group, LLC1,500$4.29K0.00%

Sold out (7)

Institutions that held Humacyte, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of HUMA in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
SG Americas Securities, LLC29,921$92.0K
Millennium Management LLC27,875$86.0K
Raymond James & Associates19,411$60.0K
Y-Intercept (Hong Kong) Ltd14,565$45.0K
Kovitz Investment Group Partners, LLC11,250$35.0K
TCI Wealth Advisors, Inc.1,557$4.81K
Ellevest, Inc.616$1.90K